Manuel Rodríguez-Perálvarez

27PUBLICATIONS
99CO-AUTHORS
Agrochemicals and biocides (incl. application)German languageHaematological tumoursSocial program evaluationCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jan 29, 2026
Excluding Ascites From the GEMA-Na Score Does Not Impact Outcome Predictions in Liver Transplant Candidates.

Manuel Luis Rodríguez-Perálvarez, Antonio Manuel Gómez-Orellana, Avik Majumdar

|Jan 30, 2025
Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma.

María L Espejo-Cruz, Sandra González-Rubio, Juan J Espejo

|Nov 04, 2024
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma.

Ezequiel Mauro, Manuel Rodríguez-Perálvarez, Antonio D'Alessio

|Sep 13, 2024
First consensus document of waiting list prioritization for liver transplantation by the Spanish Society of Liver Transplantation (SETH).

Itxarone Bilbao, Laura Lladó, Alba Cachero

|Jul 21, 2024
Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation.

Javier M Zamora-Olaya, Rocío Tejero-Jurado, Paloma E Alañón-Martínez

Pageof 5